BAKER HEART AND DIABETES INSTITUTE
- Country
- 🇦🇺Australia
- Ownership
- -
- Established
- 1858-01-01
- Employees
- 481
- Market Cap
- -
- Website
- http://www.bakeru.edu
Clinical Trials
52
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials
Exercise to Improve Neurovascular Function in Breast Cancer Survivors
- Conditions
- Breast Cancer Survivorship
- First Posted Date
- 2025-04-13
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 40
- Registration Number
- NCT06925529
- Locations
- 🇦🇺
Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
Real-World Evaluation of a Digitally Enabled Cardiac Rehabilitation Program
- Conditions
- Chronic DiseaseCardiovascular Disease PreventionHeart Disease
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 172
- Registration Number
- NCT06813482
- Locations
- 🇦🇺
Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
Echo Acquisition Despite Geographic Separation by Replication of Human Movements (EAGER)
- Conditions
- Echocardiography
- First Posted Date
- 2024-12-19
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 50
- Registration Number
- NCT06742905
- Locations
- 🇦🇺
Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor
- Conditions
- Cognitive ImpairmentLeft Ventricular DysfunctionHeart FailureDementiaCognitive ChangeCognitive Decline
- First Posted Date
- 2023-10-18
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 168
- Registration Number
- NCT06088212
- Locations
- 🇦🇺
Menzies Institute for Medical Research, Hobart, Tasmania, Australia
Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
- Conditions
- Heart FailureValve Heart Disease
- First Posted Date
- 2022-09-28
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 612
- Registration Number
- NCT05558605
- Locations
- 🇦🇺
Alice Springs Hospital, Alice Springs, Northern Territory, Australia
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
Glucotrack Secures Ethical Approval for Long-Term Clinical Study of Implantable Blood Glucose Monitor
Glucotrack has received ethical approval from St. Vincent's Hospital Melbourne HREC for a year-long clinical study of its implantable continuous blood glucose monitor in patients with type 1 and type 2 diabetes.